<DOC>
	<DOCNO>NCT00388700</DOCNO>
	<brief_summary>The purpose clinical trial determine whether combination 5-fluorouracil ( 5-FU ) plus DAVANAT ( carbohydrate polymer ) along Avastin Leucovorin ( LV ) beneficial treat colorectal cancer patient unable tolerate intensive chemotherapy .</brief_summary>
	<brief_title>A New Agent GM-CT-01 Combination With 5-FU , Avastin Leucovorin Subjects With Colorectal Cancer</brief_title>
	<detailed_description>This Phase II , multi-center study DAVANAT show increase anti-tumor activity 5-FU mouse . 5-FU chemotherapy drug commonly use treat tumor . A Phase I study 40 patient show DAVANAT different dos plus 5-FU well tolerated patient different type solid tumor fail standard , approved treatment .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>18 year old . Histologically confirm , unresectable , locally advanced metastatic colorectal adenocarcinoma ( stage III IV ) , amenable curative surgery radiotherapy . Intolerant oxaliplatin and/or irinotecan , demonstrate unacceptable toxicity trial agent firstline therapy , opinion Investigator , judge high risk unacceptable toxicity oxaliplatin and/or irinotecan , Presence least 1 measurable lesion , Have life expectancy least 4 month . Women childbearing potential , negative serum pregnancy test screen Day 1 treatment agree practice abstinence use effective method contraception . Central nervous system metastasis . Bony metastasis sole metastasis . Received prior firstline chemotherapy colorectal cancer . Previously expose DAVANAT® Avastin® . Known clinically suspect infection HIV . Participated within 30 day participate concurrently another investigational drug vaccine study . History drug alcohol dependence past 3 year . Other serious , nonmalignant , significant , acute chronic medical psychiatric illness judgment Investigator could compromise subject safety , limit subject 's ability complete study , and/or compromise objective study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Colorectal cancer , DAVANAT , colon cancer , 5-FU</keyword>
</DOC>